CWA Asset Management Group LLC Purchases Shares of 3,516 Danaher Co. (NYSE:DHR)

CWA Asset Management Group LLC bought a new position in Danaher Co. (NYSE:DHR - Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 3,516 shares of the conglomerate's stock, valued at approximately $978,000.

Other large investors have also recently bought and sold shares of the company. Equitable Trust Co. boosted its holdings in Danaher by 15.4% in the third quarter. Equitable Trust Co. now owns 12,459 shares of the conglomerate's stock worth $3,464,000 after acquiring an additional 1,661 shares in the last quarter. Leavell Investment Management Inc. raised its position in shares of Danaher by 10.0% during the third quarter. Leavell Investment Management Inc. now owns 10,951 shares of the conglomerate's stock valued at $3,048,000 after buying an additional 1,000 shares during the last quarter. Triune Financial Partners LLC bought a new position in shares of Danaher during the 3rd quarter valued at approximately $325,000. AIA Group Ltd lifted its stake in shares of Danaher by 3.4% during the 3rd quarter. AIA Group Ltd now owns 174,999 shares of the conglomerate's stock worth $48,653,000 after acquiring an additional 5,688 shares during the last quarter. Finally, Hudson Value Partners LLC lifted its holdings in Danaher by 1.5% during the 3rd quarter. Hudson Value Partners LLC now owns 23,477 shares of the conglomerate's stock valued at $6,527,000 after buying an additional 349 shares in the last quarter. 79.05% of the stock is owned by institutional investors.

Danaher Price Performance

Shares of Danaher stock traded down $2.80 during trading on Monday, reaching $242.59. 1,658,136 shares of the stock traded hands, compared to its average volume of 2,739,107. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.37 and a quick ratio of 1.01. Danaher Co. has a 52-week low of $193.75 and a 52-week high of $281.70. The business has a fifty day simple moving average of $264.89 and a two-hundred day simple moving average of $260.84. The company has a market capitalization of $175.22 billion, a price-to-earnings ratio of 47.31, a P/E/G ratio of 4.51 and a beta of 0.85.

Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings data on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share for the quarter, topping analysts' consensus estimates of $1.57 by $0.14. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The firm had revenue of $5.80 billion during the quarter, compared to analysts' expectations of $5.59 billion. During the same period in the prior year, the business posted $2.02 EPS. The firm's quarterly revenue was up 3.1% on a year-over-year basis. Sell-side analysts expect that Danaher Co. will post 7.51 EPS for the current year.

Danaher Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, October 25th. Stockholders of record on Friday, September 27th were paid a $0.27 dividend. The ex-dividend date of this dividend was Friday, September 27th. This represents a $1.08 annualized dividend and a dividend yield of 0.45%. Danaher's dividend payout ratio (DPR) is 20.61%.

Analysts Set New Price Targets

A number of analysts have commented on DHR shares. Royal Bank of Canada lowered their price target on Danaher from $333.00 to $311.00 and set an "outperform" rating for the company in a research report on Wednesday, October 23rd. The Goldman Sachs Group raised their target price on Danaher from $225.00 to $250.00 and gave the stock a "neutral" rating in a research note on Wednesday, July 24th. Stephens reissued an "overweight" rating and set a $315.00 target price on shares of Danaher in a research note on Wednesday, October 23rd. StockNews.com upgraded shares of Danaher from a "hold" rating to a "buy" rating in a research note on Wednesday, November 6th. Finally, Evercore ISI lifted their price objective on shares of Danaher from $275.00 to $278.00 and gave the company an "outperform" rating in a research note on Tuesday, October 1st. Five equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. According to data from MarketBeat.com, Danaher has an average rating of "Moderate Buy" and an average target price of $287.16.

Insider Buying and Selling at Danaher

In other Danaher news, SVP Georgeann Couchara sold 952 shares of the firm's stock in a transaction on Monday, August 26th. The shares were sold at an average price of $268.37, for a total transaction of $255,488.24. Following the transaction, the senior vice president now directly owns 4,212 shares of the company's stock, valued at approximately $1,130,374.44. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. 11.10% of the stock is currently owned by corporate insiders.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.